Efficacy and Tolerability of Citalopram in the Treatment of Late-Life Anxiety Disorders: Results From an 8-Week Randomized, Placebo-Controlled Trial
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Anxiety disorders are highly prevalent in elderly persons. However, to date, the efficacy of selective serotonin reuptake inhibitors (SSRIs) for the treatment of anxiety disorders in this age group has not been established. METHOD: Thirty-four participants age 60 and older with a DSM-IV anxiety disorder (mainly generalized anxiety disorder) and a Hamilton Anxiety Rating Scale score of 17 or higher were randomly assigned under double-blind conditions to either citalopram or placebo. Response was defined as a score of 1 (very much improved) or 2 (much improved) on the Clinical Global Improvement scale or a 50% reduction in the Hamilton anxiety scale score. Response and side effects with citalopram and placebo were compared by using chi-square tests and linear modeling. RESULTS: Eleven (65%) of the 17 citalopram-treated participants responded by 8 weeks, versus four (24%) of the 17 placebo-treated participants. The most common and problematic side effect in the citalopram group was sedation. CONCLUSIONS: The authors believe this to be the first prospective controlled study to test the efficacy of an SSRI in the management of anxiety disorders among the elderly. These results support the efficacy of citalopram in late-life anxiety disorders. They need to be replicated in a larger study group.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mediators and Moderators of Treatment Effects in Randomized Clinical Trials
Kraemer, H. C., Wilson, G. T., Fairburn, C. G., & Agras, W. S. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.10.877 · Cited by 2,562
Lingjærde, O., Ahlfors, U. G., Bech, P., Dencker, S. J., & Elgen, K. (1987) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1987.tb10566.x · Cited by 1,705
Shear, M. K., Vander Bilt, J., Rucci, P., Endicott, J., Lydiard, B., Otto, M. W., Pollack, M. H., Chandler, L., Williams, J., Ali, A., et al. (2001) · Depression and Anxiety · doi:10.1002/da.1033 · Cited by 483
Self-citationde BEURS, E., BEEKMAN, A. T. F., van BALKOM, A. J. L. M., DEEG, D. J. H., van DYCK, R., & van TILBURG, W. (1999) · Psychological Medicine · doi:10.1017/s0033291799008351 · Cited by 378
Generalized Anxiety Disorder in Stroke Patients: A 3-Year Longitudinal Study
Åström, M. (1996) · Stroke · doi:10.1161/01.str.27.2.270 · Cited by 329
Cognitive improvement following benzodiazepine discontinuation in elderly nursing home residents
Salzman, C., Fisher, J., Nobel, K., Glassman, R., Wolfson, A., & Kelley, M. (1992) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.930070205 · Cited by 117
Anxiety disorders in later life: a report from the Longitudinal Aging Study Amsterdam
Beekman (1998) · Pure Amsterdam UMC · doi:10.1002/(sici)1099-1166(1998100)13:10 · Cited by 2
Cited by
Katzman, M. A., Bleau, P., Blier, P., Chokka, P., Kjernisted, K., Van Ameringen, M., & the Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and McGill University (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-s1-s1 · Cited by 1,090
Bandelow, B., Zohar, J., Hollander, E., Kasper, S., Möller, H.-J., WFSBP TASK FORCE ON TREATMENT GUIDE, Bandelow, B., Zohar, J., Hollander, E., Kasper, S., et al. (2008) · The World Journal of Biological Psychiatry · doi:10.1080/15622970802465807 · Cited by 854
Baldwin, D. S., Anderson, I. M., Nutt, D. J., Bandelow, B., Bond, A., Davidson, J. R. T., den Boer, J. A., Fineberg, N. A., Knapp, M., Scott, J., et al. (2005) · Journal of Psychopharmacology · doi:10.1177/0269881105059253 · Cited by 617
Identifying HAM‐A cutoffs for mild, moderate, and severe generalized anxiety disorder
Matza, L. S., Morlock, R., Sexton, C., Malley, K., & Feltner, D. (2010) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.323 · Cited by 269
Evidence-based psychological treatments for late-life anxiety
Ayers, C. R., Sorrell, J. T., Thorp, S. R., & Wetherell, J. L. (2007) · Psychology and Aging · doi:10.1037/0882-7974.22.1.8 · Cited by 235
A lifespan view of anxiety disorders
Lenze, E. J., & Wetherell, J. L. (2011) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2011.13.4/elenze · Cited by 227
Self-citationInterventions for generalized anxiety disorder in older adults: Systematic review and meta-analysis
Gonçalves, D. C., & Byrne, G. J. (2012) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2011.08.010 · Cited by 227
Rief, W., Nestoriuc, Y., von Lilienfeld-Toal, A., Dogan, I., Schreiber, F., Hofmann, S. G., Barsky, A. J., & Avorn, J. (2009) · Drug Safety · doi:10.2165/11316580-000000000-00000 · Cited by 202
Cognitive-behavioural therapy for late-life anxiety disorders: a systematic review and meta-analysis
Hendriks, G. J., Oude Voshaar, R. C., Keijsers, G. P. J., Hoogduin, C. A. L., & Van Balkom, A. J. L. M. (2008) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2008.01190.x · Cited by 184
Meta-analysis comparing different behavioral treatments for late-life anxiety
Thorp, S. R., Ayers, C. R., Nuevo, R., Stoddard, J. A., Sorrell, J. T., & Wetherell, J. L. (2009) · The American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e31818b3f7e · Cited by 134
Lenze, E. J., Mulsant, B. H., Mohlman, J., Shear, M. K., Dew, M. A., Schulz, R., Miller, M. D., Tracey, B., & Reynolds, C. F. (2005) · The American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200501000-00011 · Cited by 132
Self-citationSystematic review and meta-analysis: dose-response curve of SSRIs and SNRIs in anxiety disorders
Jakubovski, E., Johnson, J. A., Nasir, M., Müller-Vahl, K., & Bloch, M. H. (2019) · Depression and Anxiety · doi:10.1002/da.22854 · Cited by 131
Pinquart, M., & Duberstein, P. R. (2007) · The American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e31806841c8 · Cited by 126
Schuurmans, J., Comijs, H., Emmelkamp, P. M. G., Gundy, C. M. M., Weijnen, I., van den Hout, M., & van Dyck, R. (2006) · The American Journal of Geriatric Psychiatry · doi:10.1097/01.jgp.0000196629.19634.00 · Cited by 102
Evidence-based treatment of geriatric anxiety disorders
Wetherell, J. L., Lenze, E. J., & Stanley, M. A. (2005) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2005.09.006 · Cited by 94
Self-citationNew Research on Anxiety Disorders in the Elderly and an Update on Evidence-Based Treatments
Andreescu, C., & Varon, D. (2015) · Current Psychiatry Reports · doi:10.1007/s11920-015-0595-8 · Cited by 85
Modular psychotherapy for anxiety in older primary care patients
Wetherell, J. L., Ayers, C. R., Sorrell, J. T., Thorp, S. R., Nuevo, R., Belding, W., Gray, E., Stanley, M. A., Areán, P. A., Donohue, M., et al. (2009) · The American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181a31fb5 · Cited by 78
“Data suggest that anxiolytic medications are effective for geriatric anxiety (9,10).”
BackgroundLenze, E. J., & Wetherell, J. L. (2009) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2074 · Cited by 57
Self-citationSchuurmans, J., Comijs, H., Emmelkamp, P. M. G., Weijnen, I. J. C., van den Hout, M., & van Dyck, R. (2009) · International Psychogeriatrics · doi:10.1017/s1041610209990536 · Cited by 48
Meta-analysis: Risk of dry mouth with second generation antidepressants
Cappetta, K., Beyer, C., Johnson, J. A., & Bloch, M. H. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.12.012 · Cited by 49
Antidepressants versus placebo for generalised anxiety disorder (GAD)
Kopcalic, K., Arcaro, J., Pinto, A., Ali, S., Barbui, C., Curatoli, C., Martin, J., & Guaiana, G. (2025) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012942.pub2 · Cited by 16
Anxiety Disorders in Later Life
Johnco, C. J., Matovic, D., & Wuthrich, V. M. (2024) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2024.04.015 · Cited by 12
Escitalopram for Older Adults With Generalized Anxiety Disorder: A Randomized Controlled Trial
Lenze, E. J., Rollman, B. L., Shear, M. K., Dew, M. A., Pollock, B. G., Ciliberti, C., Costantino, M., Snyder, S., Shi, P., Spitznagel, E., et al. (2009) · JAMA · doi:10.1001/jama.2008.977 · Cited by 5
Self-citation
Metadata
- Authors
- Lenze, E. J., Mulsant, B. H., Shear, M. K., Dew, M. A., Miller, M. D., Pollock, B. G., Houck, P., Tracey, B., & Reynolds, C. F.
- Venue
- American Journal of Psychiatry
- Published
- 2005-01-01
- Volume
- 162
- Issue
- 1
- Pages
- 146-150
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2121863088
- Cited by
- 121
- References
- 7
- FWCI
- 7.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.